Ruxolitinib treatment for bronchiolitis obliterans syndrome following hematopoietic stem cell transplant in a patient with primary hemophagocytic lymphohistiocytosis.

Ruxolitinib treatment for bronchiolitis obliterans syndrome following hematopoietic stem cell transplant in a patient with primary hemophagocytic lymphohistiocytosis. Chin Med J (Engl). 2021 Jan 05;Publish Ahead of Print: Authors: Meng GQ, Wang YN, Wang JS, Wang Z PMID: 33410634 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33410634?dopt=Abstract

Source: Chinese Medical Journal - January 5, 2021 Category: General Medicine Authors: Meng GQ, Wang YN, Wang JS, Wang Z Tags: Chin Med J (Engl) Source Type: research